Opening company profile

Loading company metrics, contact preview, and tender history.

Loading…

Nucleus Bioscience

Overview

Public records across all portals

Total bids

Bids on record

Awarded bids

0 lost · 0 pending

Awarded value

₹0

of ₹1.3 Cr bid · 0.0% conversion

Win rate

0.0%

of 1 bids

Bid outcomes

By count1 bids

Tech rejected1100.0%

By value₹1.3 Cr

Tech rejected₹1.3 Cr100.0%

Organisations

Top organisations

No organisation data

Try another outcome or period.

Operating states

No state data

Try another outcome or period.

Tender history

Org Chain

Tender

Est. Cost

This Company

Finance Department - World Bank Tenders

Assam State Public Finance Institutional Reforms

Assam

AOC

Procurement of Scientific Instruments and Related Services for Modernization of Assam Excise Chemical Laboratory at Guwahati Biotech Park, Assam

Guwahati | Kamrup Metro, AssamAOC Updated 5 Apr 2023

Biogene Scientific

₹8.8 L

Nucleus Bioscience

Tech Rejected

Finance Department - World Bank Tenders

Assam State Public Finance Institutional Reforms

Tech Rejected

Procurement of Scientific Instruments and Related Services for Modernization of Assam Excise Chemical Laboratory at Guwahati Biotech Park, Assam

Guwahati | Kamrup Metro, AssamAOC Updated 5 Apr 2023

Assam

AOC

Assam

AOC

EstNot disclosed

Est

Biogene Scientific

₹8.8 L

Nucleus Bioscience

Tech Rejected

Biogene Scientific

₹8.8 L

This company

Nucleus Bioscience

Tech Rejected

This profile is built from what portals disclose publicly. Since several states never release bidder lists or quoted prices, it likely understates the company’s true footprint. A tender is counted as won when the company either received the award or stood L1 at financial bid opening, even if the formal award is still pending. TenderKart compiles these public records independently and has no association with any government portal, buyer, or bidder.